Gamma Biosciences

Private Investment Firm Menlo Park, United States ·Founded 2019

Overview

Gamma Biosciences is a private investment firm dedicated to advancing the development and production of biopharmaceuticals. The firm collaborates with small to mid-sized companies to provide capital and expertise, aiming to accelerate the growth of innovative therapies. Established in 2019 in partnership with KKR & Co., Gamma Biosciences has invested nearly $300 million into early and mid-stage businesses within the biomanufacturing value chain. The firm's portfolio includes Astrea Bioseparations, a UK-based leader in affinity chromatography and process purification, and Univercells, a Belgium-based company specializing in biomanufacturing equipment. Gamma Biosciences leverages its collective industry experience and network to support companies in the biopharmaceutical sector, focusing on next-generation bioprocessing technologies for advanced biologic therapies. The firm is headquartered in Menlo Park, California, and operates in the United States, United Kingdom, and Belgium.

Investment Focus

  • Innovative biopharmaceutical companies
  • Advanced biologic therapies
  • Experienced management teams

Portfolio Companies

UnivercellsAstrea Bioseparations

Reach Gamma Biosciences directly

Verified work email, phone and LinkedIn for the full team — one spreadsheet, one payment, yours to keep.

Unlock full contacts →

Frequently asked questions about Gamma Biosciences

What sectors does Gamma Biosciences invest in?

Gamma Biosciences invests in Healthcare, Pharmaceuticals, Medical Devices and Biotechnology, and is based in Menlo Park, United States. Gamma Biosciences is listed as a private investment firm in the ConnectSafely investor database.

What stage does Gamma Biosciences invest at?

Gamma Biosciences backs companies at Growth and Late Stage.

Which regions does Gamma Biosciences invest in?

Gamma Biosciences invests across United States, United Kingdom and Belgium.

Who are the partners at Gamma Biosciences?

Team members listed for Gamma Biosciences include Matt Gunnison (Chief Executive Officer) and Gabe Longoria (Owner).

What companies has Gamma Biosciences invested in?

Gamma Biosciences's portfolio includes Univercells and Astrea Bioseparations.

How do I contact Gamma Biosciences?

Gamma Biosciences's contact details — including LinkedIn — are listed in the ConnectSafely investor database, along with its website and the LinkedIn profiles of its partners.

Last updated · Source: ConnectSafely investor database